CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1 Dose Escalation Study to Assess the Safety and Immunogenicity of a Monovalent Virus-Like Particle (VLP) Venezuelan Equine Encephalitis Vaccine in Healthy Adults

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03776994
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:18.108609+00:00
Published At: 2021-02-23T00:00:00+00:00
Record Updated At: 2021-02-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Encephalitis", "Encephalitis, Viral", "Infectious Encephalitis", "Virus Diseases", "Encephalomyelitis, Venezuelan Equine", "Brain Diseases", "Central Nervous System Diseases", "Central Nervous System Viral Diseases", "Alphavirus Infections", "Togaviridae Infections", "RNA Virus Infections", "Central Nervous System Infections", "Encephalomyelitis", "Physiological Effects of Drugs", "Vaccines", "Encephalomyelitis, Equine", "Nervous System Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-02-23"
protocolSection.identificationModule.nctId: "NCT03776994"
protocolSection.identificationModule.officialTitle: "A Phase 1 Dose Escalation Study to Assess the Safety and Immunogenicity of a Monovalent Virus-Like Particle (VLP) Venezuelan Equine Encephalitis Vaccine in Healthy Adults"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.